Feng Zhengzhe, Zhang Lei, Li Qiang, Zhao Rui, Xu Yi, Hong Bo, Zhao Wenyuan, Liu Jianmin, Huang Qinghai
Department of Neurosurgery, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai 200433, China.
Department of Neurology, Shandong Ji'ning First People's Hospital, Ji'ning, China.
J Clin Neurosci. 2015 Aug;22(8):1288-91. doi: 10.1016/j.jocn.2015.02.020. Epub 2015 Jun 6.
We performed this retrospective study to assess the clinical safety and efficacy of the low-profile visualized intraluminal support junior (LVIS Jr.; MicroVention, Aliso Viejo, CA, USA) stent placement in anterior communicating artery (ACA) aneurysms. ACA aneurysms are some of the most common intracranial aneurysms. Stent placement is particularly difficult due to the complexity of the vascular anatomy and the small vessels of the ACA complex. From November 2013 and June 2014, LVIS Jr. stent-assisted coiling was performed in 11 patients with 12 wide-neck ACA aneurysms. Patient demographics, morphologic features of the aneurysm, clinical results and follow-up results are presented. Successful deployment of the LVIS Jr. stent in the targeted artery was achieved in all patients. Complete occlusion was achieved in seven patients, neck remnant in three, and partial occlusion in two. The angiographic follow-up of nine patients (mean 4.4 months) showed that all aneurysms remained stable or improved. There was no in-stent stenosis, recurrence or retreatment. The modified Rankin scale score at discharge was 0 in eight patients and 1 in three patients. The LVIS Jr. stent provided excellent trackability and deliverability and is safe and effective for the treatment of wide-necked ACA aneurysms. Further follow-up is needed to assess the long-term efficacy of LVIS Jr. stent placement in ACA.
我们进行了这项回顾性研究,以评估低轮廓可视化腔内支撑小号支架(LVIS Jr.;美国加利福尼亚州阿利索维耶霍市MicroVention公司)植入前交通动脉(ACA)动脉瘤的临床安全性和有效性。ACA动脉瘤是最常见的颅内动脉瘤之一。由于血管解剖结构复杂以及ACA复合体血管细小,支架植入尤其困难。2013年11月至2014年6月,对11例患有12个宽颈ACA动脉瘤的患者进行了LVIS Jr.支架辅助弹簧圈栓塞术。本文介绍了患者的人口统计学资料、动脉瘤的形态学特征、临床结果及随访结果。所有患者均成功将LVIS Jr.支架植入目标动脉。7例患者实现完全闭塞,3例有颈部残余,2例部分闭塞。9例患者(平均随访4.4个月)的血管造影随访显示,所有动脉瘤均保持稳定或有所改善。未出现支架内狭窄、复发或再次治疗情况。出院时改良Rankin量表评分为0分的患者有8例,1分的有3例。LVIS Jr.支架具有出色的可跟踪性和可输送性,治疗宽颈ACA动脉瘤安全有效。需要进一步随访以评估LVIS Jr.支架植入ACA动脉瘤的长期疗效。